Podcasts

Episode 22 | Accelerating Progress in Oncogene-driven Lung Cancer

Dr Deme Karikios, Dr Wanda Cui and A/Prof Chris Karapetis discuss the advances in oncogene-driven lung cancer and what this means for trial design, patients and treatment practices in Australia.

Accelerating Progress in Oncogene-driven Lung Cancer

Episode Summary

Join us for the latest TOGA podcast about Accelerating Progress in Oncogene-driven Lung Cancer. Dr Deme Karikios, Dr Wanda Cui and A/Prof Chris Karapetis discuss the advances in oncogene-driven lung cancer and what this means for trial design, patients and treatment practices in Australia. We examine the survival data for the common and not so common mutated lung cancers, as well as the future view.

Show Hosts

This episode’s host are:

Dr Deme Karikios, Medical Oncologist and Director of Clinical Trials, Nepean Cancer Centre
Dr Wanda Cui, Medical Oncologist, Peter MacCallum Cancer Centre
A/Prof Chris Karapetis, Head of the Department of Medical Oncology and Director of Clinical Research, Flinders Medical Centre

Play Episode 22 | Accelerating Progress in Oncogene-driven Lung Cancer

More Podcasts

51 – Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy

Podcasts
May 9, 2025

In this episode, Prof Tom John, Prof Georgina Long AO, and Prof Ken O'Byrne delve into technological advances spurred by COVID-19 vaccine development, promising results

50 – The Role of Liquid Biopsy in Modern Oncology

Podcasts
March 21, 2025

In this episode, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Steven Kao discuss the concept of liquid biopsy, its advantages and limitations, and its

49 – Exploring EGFR Exon 20 Insertion Mutations

Podcasts
March 7, 2025

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into

48 – A Conversation with Prof. Michael Boyer

Podcasts
February 6, 2025

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and

47 – Introducing Conversations in Lung Cancer Research

Podcasts
February 6, 2025

In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'

46 – Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy

Podcasts
December 13, 2024

Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC

Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

TOGA

Quicklinks

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.